<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Nuclear Medicine &#187; activation</title>
	<atom:link href="http://esnms.com/tag/activation/feed/" rel="self" type="application/rss+xml" />
	<link>http://esnms.com</link>
	<description></description>
	<lastBuildDate>Fri, 10 Sep 2010 12:20:00 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>RXR activation &#8212; hope for new Parkinson&#8217;s disease treatment</title>
		<link>http://esnms.com/rxr-activation-hope-for-new-parkinsons-disease-treatment/13/</link>
		<comments>http://esnms.com/rxr-activation-hope-for-new-parkinsons-disease-treatment/13/#comments</comments>
		<pubDate>Sat, 26 Sep 2009 12:30:51 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[nuclear medicine articles]]></category>
		<category><![CDATA[activation]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[hope]]></category>
		<category><![CDATA[Parkinson's]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://esnms.com/?p=13</guid>
		<description><![CDATA[RXR activation &#8212; hope for new Parkinson&#8217;s disease treatment
Researchers have investigated the potential of RXR ligands for the treatment of Parkinson&#8217;s disease. Writing in the open-access journal BMC Neuroscience the scientists describe the use of two cellular models of Parkinsonian damage to explore the neuroprotective function of the two RXR ligands LG268 and XCT.
Read more [...]]]></description>
			<content:encoded><![CDATA[<p><b>RXR activation &#8212; hope for new Parkinson&#8217;s disease treatment</b><br />
Researchers have investigated the potential of RXR ligands for the treatment of Parkinson&#8217;s disease. Writing in the open-access journal BMC Neuroscience the scientists describe the use of two cellular models of Parkinsonian damage to explore the neuroprotective function of the two RXR ligands LG268 and XCT.</p>
<p>Read more on <a href="http://www.eurekalert.org/pub_releases/2009-12/bc-ra120909.php">EurekAlert!</a><br/><br/></p>
]]></content:encoded>
			<wfw:commentRss>http://esnms.com/rxr-activation-hope-for-new-parkinsons-disease-treatment/13/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
